PDF
Easy Read
Abridged PDF
Respond to this article- Versions
- bmj.39350.617616.BEv1
- 335/7625/875 most recent
- Sara N Bleich, assistant professor1,
- David M Cutler, dean of social sciences2,
- Alyce S Adams, assistant professor3,
- Rafael Lozano, director general of information4,
- Christopher J L Murray, director5
- 1Johns Hopkins School of Public Health, Baltimore, MD 21205, USA
- 2Harvard University Faculty of Arts and Sciences, Cambridge, MA
- 3Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA
- 4Secretaría de Salud, Mexico DF, Mexico
- 5Institute of Health Metrics and Evaluation, University of Washington, Seattle, WA
- Correspondence to: S N Bleich sbleich@jhsph.edu
- Accepted 18 September 2007
Abstract
Objective To examine the independent and combined contributions of insurance status and supply of health professionals on coverage of antihypertensive treatment among adults in Mexico.
Design Population based study.
Setting Mexico.
Participants 4032 hypertensive adults (2967 uninsured and 1065 insured): 1065 uninsured adults matched with 1065 adults insured through Seguro Popular, a programme to expand health insurance coverage to uninsured people in Mexico.
Main outcome measures Coverage of antihypertensive treatment and coverage of antihypertensive treatment with control of blood pressure.
Results Rates of treatment for hypertension varied by insurance status and supply of health professionals. Hypertensive adults insured through Seguro Popular had a significantly higher probability of receiving antihypertensive treatment (odds ratio 1.50, 95% confidence interval 1.27 to 1.78) and receiving antihypertensive treatment with control of blood pressure (1.35, 1.00 to 1.82). Greater supply of health professionals in areas with coverage through Seguro Popular was a significant predictor of antihypertensive treatment after adjusting for covariates (1.49, 1.00 to 2.20).
Conclusions Expansion of healthcare coverage to uninsured people in Mexico was associated with greater use of antihypertensive treatment and blood pressure control, particularly in areas with a greater supply of health professionals.
Footnotes
We thank Michael Law, Emmanuela Gakidou, Goodarz Danaei, Gretchen Stevens, and Majid Ezzati for help with the analysis, and the Secretaría de Salud, who created the datasets used in this study.
Contributors: SNB, DMC, AA, and CJLM conceived the study and developed the hypotheses. SNB analysed the data. All authors contributed to the interpretation of study findings. SNB drafted the manuscript and all authors contributed to the final draft. SNB is the guarantor.
Funding: Harvard Graduate School of Arts and Sciences dissertation completion fellowship.
Competing interests: None declared
Ethical approval: Not required.
- Accepted 18 September 2007
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Cholinesterase inhibitors and memantine for symptomatic treatment of dementia
Published 27 May 2012
Re: Time to end the distinction between mental and neurological illnesses
Published 27 May 2012
Re: Influenza vaccination in healthcare professionals
Published 27 May 2012
Greek doctors are required to deliver care all week at no cost!
Published 27 May 2012
Re: What is recall bias?
Published 27 May 2012
Most responses
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 (12 responses)
Published 10 May 2012 - 23:32
The psychiatric oligarchs who medicalise normality (9 responses)
Published 2 May 2012
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
The hardest thing: admitting error (7 responses)
Published 2 May 2012 - 12:27